Department of Human Pathology, Wakayama Medical University, Kimiidera, Wakayama Japan.
J Clin Pathol. 2011 Apr;64(4):325-9. doi: 10.1136/jcp.2010.083956. Epub 2011 Feb 4.
Loss of cellular polarity/cohesiveness (LOP/C) in the invasive front of papillary thyroid carcinoma (PTC) results in a high recurrence risk of PTC.
To investigate the immunohistochemical features of LOP/C in PTC and to show that this feature is linked to a high association of lymph node metastasis (LNM) at surgery and tumour recurrence.
The degree of LOP/C of the PTCs was evaluated histologically using a cut-off value of 20% and the immunohistochemical features of LOP/C were analysed using immunohistochemical staining for E-cadherin, β-catenin and vimentin. The relationship between the LOP/C and the other clinicopathological parameters was analysed.
43 cases of PTC with LOP/C (≥20%) were selected and 27 cases with LOP/C (<20%) were included as control tumours. 11/44 cases (25%) were observed to develop recurrence, LNM or distant metastasis at an average follow-up of 31 months. Less expression of E-cadherin and aberrant localisation of β-catenin and vimentin were observed in PTC tumour cells with LOP/C. LOP/C (≥20%) was significantly correlated with extrathyroid invasion (r=0.336, p=0.003), advanced tumour stage (r=0.275, p=0.017), LNM (r=0.389, p<0.001) and recurrence after surgery (r=0.302, p=0.036). Both extrathyroid invasion and LOP/C were independent significant predictors of LNM.
LOP/C may be a useful morphological feature of epithelial mesenchymal transition under H&E observation, and it is an important indicator of lymph node metastasis and aggressive clinical behaviour of PTC.
甲状腺乳头状癌(PTC)侵袭前沿的细胞极性/黏附丧失(LOP/C)导致 PTC 复发风险增加。
研究 PTC 中 LOP/C 的免疫组织化学特征,并表明该特征与手术时淋巴结转移(LNM)和肿瘤复发的高关联性相关。
使用 20%的截断值评估 PTC 的 LOP/C 程度,并使用 E-钙黏蛋白、β-连环蛋白和波形蛋白的免疫组织化学染色分析 LOP/C 的免疫组织化学特征。分析 LOP/C 与其他临床病理参数之间的关系。
选择 43 例 LOP/C(≥20%)的 PTC 病例,并纳入 27 例 LOP/C(<20%)的对照肿瘤。在平均 31 个月的随访中,11/44 例(25%)患者发生复发、LNM 或远处转移。在具有 LOP/C 的 PTC 肿瘤细胞中,E-钙黏蛋白的表达减少,β-连环蛋白和波形蛋白的局部定位异常。LOP/C(≥20%)与甲状腺外侵犯(r=0.336,p=0.003)、肿瘤晚期(r=0.275,p=0.017)、LNM(r=0.389,p<0.001)和术后复发(r=0.302,p=0.036)显著相关。甲状腺外侵犯和 LOP/C 均是 LNM 的独立显著预测因子。
LOP/C 可能是 H&E 观察下上皮间质转化的有用形态特征,是 PTC 淋巴结转移和侵袭性临床行为的重要指标。